This titration schedule helps minimise gastrointestinal side effects, which are the most commonly reported adverse reactions
A combination of interrelated effectors such as glutamate excitotoxicity, mitochondria dysfunction, glial cell pathology, impaired axonal transport, protein aggregations, and neurotrophic factor deficits leads to progressive motor neuron degeneration and eventual death
Research Profile Cagrilintide is being studied as a combination therapy partner most notably with semaglutide in the CagriSema combination with Phase 3 data showing additive weight reduction effects beyond either compound alone
Each patients experience is unique, and individual results can vary based on adherence to the recommended lifestyle modifications, personal medical history, and other individual factors
The glucose challenge (OGTT) demonstrated increased plasma glucose levels for the stroke patients compared to the healthy controls (7.8 vs